Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2013-10-31
2017-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The effect of the treatment will be measured by the change from baseline in Visual acuity and in Stereoscopic Vision; and to assess the ease of use of and compliance by the patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dichoptic Video Treatment for Amblyopia
NCT03825107
Amblyopia Treatment for Children Aged 8 to 12 Years
NCT07281742
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
NCT06524882
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
NCT06380517
Dichoptic Virtual Reality Therapy for Amblyopia in Adults
NCT02246556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
Daily watching videos using Reviview™, a dichoptic video display device
Daily watching videos using Reviview™, a dichoptic video display device, for 60 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Daily watching videos using Reviview™, a dichoptic video display device, for 60 min
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
(1) Refractive Amblyopia, visual acuity score \<6:15 (worse then)
* or (2) Strabismic Amblyopia, visual acuity score between 6:15 and 6:30
Exclusion Criteria
4 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Visior Technologies Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haim Stolovitch, MD
Role: PRINCIPAL_INVESTIGATOR
Tel-Aviv Sourasky Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel-Aviv Sourasky Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RV-TMSC-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.